|
|||||
|
|

Scientific consulting firm Exponent (NASDAQ:EXPO) beat Wall Street’s revenue expectations in Q4 CY2025, with sales up 4.5% year on year to $129.4 million. Its non-GAAP profit of $0.49 per share was 3.6% above analysts’ consensus estimates.
Is now the time to buy EXPO? Find out in our full research report (it’s free for active Edge members).
Exponent delivered results ahead of Wall Street expectations in Q4, with management crediting growth in both proactive and reactive consulting engagements. CEO Catherine Corrigan highlighted increased demand for user research in consumer electronics—particularly as artificial intelligence becomes more deeply embedded in novel devices—and noted ongoing expansion of risk management work within the utility sector. Corrigan also pointed to a broadening of failure analysis and dispute-related projects across sectors like energy, construction, and transportation as major contributors to quarterly performance. She stated, “Exponent thrives at the edge where AI meets the laws of physics in high-stakes environments where reliability, performance and security cannot be compromised.”
Looking ahead, Exponent’s forward guidance is anchored by expectations of sustained demand as clients contend with increasing technological complexity and regulatory requirements. Management believes that broader adoption of AI in critical industries will continue to drive demand for multidisciplinary expertise, especially in areas such as utilities, medical devices, and transportation. CFO Richard Schlenker emphasized that the company anticipates high single-digit growth for 2026, supported by rising headcount and improved utilization. Corrigan also noted, “As artificial intelligence and other advanced technologies become more deeply embedded in novel products and critical systems, clients are facing an expanding set of complex high stakes challenges.”
Management attributed the quarter’s growth to diversified demand for consulting services across proactive and reactive projects, with notable momentum in AI-related engagements and utility-sector risk management.
Exponent expects strong growth to continue, driven by rising technological complexity, AI integration, and ongoing regulatory and infrastructure needs across its core markets.
Looking ahead, our analysts will closely monitor (1) the pace of adoption and scale of AI-driven consulting projects, (2) continued diversification in client base and engagement types—particularly in utility risk management and medical devices, and (3) Exponent’s ability to maintain or expand margins as headcount and utilization rise. The evolution of regulatory frameworks and the integration of AI in safety-critical industries will also be important signposts for sustained demand.
Exponent currently trades at $70.83, in line with $70.83 just before the earnings. At this price, is it a buy or sell? See for yourself in our full research report (it’s free).
The market’s up big this year - but there’s a catch. Just 4 stocks account for half the S&P 500’s entire gain. That kind of concentration makes investors nervous, and for good reason. While everyone piles into the same crowded names, smart investors are hunting quality where no one’s looking - and paying a fraction of the price. Check out the high-quality names we’ve flagged in our Top 6 Stocks for this week. This is a curated list of our High Quality stocks that have generated a market-beating return of 244% over the last five years (as of June 30, 2025).
Stocks that have made our list include now familiar names such as Nvidia (+1,326% between June 2020 and June 2025) as well as under-the-radar businesses like the once-micro-cap company Tecnoglass (+1,754% five-year return). Find your next big winner with StockStory today.
| Mar-06 | |
| Mar-05 | |
| Mar-01 | |
| Feb-27 | |
| Feb-25 | |
| Feb-13 | |
| Feb-12 | |
| Feb-09 | |
| Feb-09 | |
| Feb-06 | |
| Feb-06 | |
| Feb-06 | |
| Feb-05 | |
| Feb-05 | |
| Feb-05 |
Join thousands of traders who make more informed decisions with our premium features. Real-time quotes, advanced visualizations, backtesting, and much more.
Learn more about Finviz Elite